Evidence map›Paper›PMID 18725259›Full record

ArticleNeurochemistry international2008

Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.

Munish Kumar, Neetu Tyagi, Karni S Moshal, Utpal Sen, Soumi Kundu, Paras K Mishra, Srikanth Givvimani, Suresh C Tyagi

Open access · greenAbstract read
In one paragraph

Article in Neurochemistry international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Effect ofPhysiological genomics · 2019
    Article
  5. Article
  6. Article
  7. Role of Homocysteine in Cognitive Impairement and Alzheimer's Disease.Indian journal of clinical biochemistry : IJCB · 2018
    Review
  8. Article
  9. Review
  10. Article
  11. Hyperhomocysteinemia promotes vascular remodeling in vein graph in mice.Frontiers in bioscience (Landmark edition) · 2014
    Article
  12. Article
  13. Article
  14. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2013
    Article
  15. Hyperhomocysteinemia during aortic aneurysm, a plausible role of epigenetics.International journal of physiology, pathophysiology and pharmacology · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Autophagy mechanism of right ventricular remodeling in murine model of pulmonary artery constriction.American journal of physiology. Heart and circulatory physiology · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Munish KumarDepartment of Physiology & Biophysics, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Neetu Tyagi
Karni S Moshal
Utpal Sen
Soumi Kundu
Paras K Mishra
Srikanth Givvimani
Suresh C Tyagi
University of Louisville · USUniversity of Louisville Hospital · US

Funding

Mechanism of Vascular Remodeling in HyperhomocysteinemiaR01HL071010 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI TYAGI, SURESH C. · 2002 to 2010
$2.7M
Mechanisms of Cerebral Vascular RemodelingR01NS051568 · NINDS · UNIVERSITY OF LOUISVILLE · PI TYAGI, SURESH C. · 2007 to 2011
$1.6M
NHLBI NIH HHS HL-71010NHLBI NIH HHS R01 HL071010NINDS NIH HHS NS-51568NINDS NIH HHS R01 NS051568
6 · The paper itself

Abstract

An elevated level of Homocysteine (Hcy) is a risk factor for vascular dementia and stroke. Cysthathionine beta Synthase (CBS) gene is involved in the clearance of Hcy. Homozygous individuals for (CBS-/-) die early, but heterozygous for (CBS-/+) survive with high levels of Hcy. The gamma-Amino Butyric Acid (GABA) presents in the central nervous system (CNS) and functions as an inhibitory neurotransmitter. Hcy competes with GABA at the GABA(A) receptor and affects the CNS function. We hypothesize that Hcy causes a decrease in blood flow to the brain due to increase in vascular resistance (VR) because of arterial remodeling in the carotid artery (CA). Blood pressure and blood flow in CA of wild type (WT), CBS-/+, CBS-/+ GABA(A)-/- double knockout, and GABA(A)-/- were measured. CA was stained with trichrome, and the brain permeability was measured. Matrix Metalloproteinases (MMP-2 and MMP-9), tissue inhibitor of metalloproteinase (TIMP-3, TIMP-4), elastin, and collagen-III expression were measured by real-time polymerase chain reaction (RT-PCR). Results showed an increase in VR in CBS-/+/GABA(A)-/-double knockout>CBS-/+/>GABA(A)-/- compared to WT mice. Increased MMP-2, MMP-9, collagen-III and TIMP-3 mRNA levels were found in GABA(A)-/-, CBS-/+, CBS-/+/GABA(A) double knockout compared to WT. The levels of TIMP-4 and elastin were decreased, whereas the levels of MMP-2, MMP-9 and TIMP-3 increased, which indirectly reflected the arterial resistance. These results suggested that Hcy caused arterial remodeling in part, by increase in collagen/elastin ratio thereby increasing VR leading to the decrease in CA blood flow.

Indexed as

AnimalsBrain IschemiaCarotid ArteriesCerebrovascular CirculationCollagenCollagen Type IIICystathionine beta-SynthaseDown-RegulationElastingamma-Aminobutyric AcidHomocysteineMatrix MetalloproteinasesMiceMice, Inbred C57BLReceptors, GABA-ARNA, MessengerCollagenCollagen Type IIICystathionine beta-SynthaseElastingamma-Aminobutyric AcidHomocysteineMatrix MetalloproteinasesReceptors, GABA-ARNA, MessengerTissue Inhibitor of Metalloproteinases

Identifiers

PMID18725259
PMCPMC2744101
OpenAlexW1998637744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.